Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China · Delayed Price · Currency is CNY 42.15
-0.11 (-0.26%)
At close: Feb 13, 2026
SHA:603590 Market Cap
SHA:603590 has a market cap or net worth of 6.7 billion as of February 13, 2026. Its market cap has increased by 85.33% in one year.
Market Cap
6.70B
Enterprise Value
6.35B
Revenue
871.31M
Ranking
n/a
PE Ratio
115.91
Stock Price
42.15
Market Cap Chart
Since August 27, 2018, SHA:603590's market cap has increased from 5.61B to 6.70B, an increase of 19.51%. That is a compound annual growth rate of 2.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 6.70B | 6.04% |
| Dec 31, 2025 | 6.32B | 69.72% |
| Dec 31, 2024 | 3.72B | -37.51% |
| Dec 29, 2023 | 5.96B | 52.69% |
| Dec 30, 2022 | 3.90B | -23.24% |
| Dec 31, 2021 | 5.08B | -12.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wuhan Keqian Biology Co.,Ltd | 7.53B |
| R&G PharmaStudies | 7.43B |
| Jiangsu Aidea Pharmaceutical Group | 7.36B |
| Shenzhen Weiguang Biological Products | 7.00B |
| GemPharmatech | 6.98B |
| Shanghai OPM Biosciences | 6.85B |
| Xiangxue Pharmaceutical | 6.22B |
| PharmaResources (Shanghai) | 6.22B |